Stock NAVB NAVIDEA BIOPHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Navidea Biopharmaceuticals, Inc.

Equities

NAVB

US63937X2027

Market Closed - OTC Markets
Other stock markets
 16:45:48 20/05/2024 BST 		5-day change 1st Jan Change
0.03 USD +15.38% Intraday chart for Navidea Biopharmaceuticals, Inc. -14.29% -45.65%
2023 Navidea Biopharmaceuticals, Inc. announced that it expects to receive $0.75 million in funding CI
2023 Navidea Biopharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
1e88c77fda2fb0b.ThyLzGH8BIPc3ShqLE7xi9R9_ZpiBUwPNW4yI_69yLk.GlPolSKvZ7rq73hZcxmB3YAWlaoaUSBAZBgDb6bb-fEfS8aJV8t-7YOzfQ~616c0c299f57c7950a7771634ea67ff2
  1. Stock Market
  2. Equities
  3. NAVB Stock
  4. Charts Navidea Biopharmaceuticals, Inc.
  5. News Chart